fluorodeoxyglucose f18 has been researched along with Lipodystrophy in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ayer, A; Cariou, B; Charpentier, F; Dollet, L; Jagu, B; Joubert, M; Le May, C; Magré, J; Manrique, A; Marechal, X; Montaigne, D; Prieur, X; Staels, B; Tesse, A; Toumaniantz, G | 1 |
| Ankrah, A; Kgomo, M; Maes, A; Sathekge, M; Stolz, A; Van de Wiele, C | 1 |
| Sathekge, MM; Warwick, JM | 1 |
| Behrens, GM; Boerner, AR; Brabant, G; Ockenga, J; Schmidt, RE; van den Hoff, J; Weber, K | 1 |
1 review(s) available for fluorodeoxyglucose f18 and Lipodystrophy
| Article | Year |
|---|---|
PET/CT scanning with a high HIV/AIDS prevalence.
Topics: Acquired Immunodeficiency Syndrome; Central Nervous System Neoplasms; False Positive Reactions; Fluorodeoxyglucose F18; HIV Seropositivity; Humans; Lipodystrophy; Lymph Nodes; Lymphoma; Positron-Emission Tomography; Prevalence; Radionuclide Imaging; Radiopharmaceuticals; Thymus Gland; Tomography, X-Ray Computed | 2011 |
1 trial(s) available for fluorodeoxyglucose f18 and Lipodystrophy
| Article | Year |
|---|---|
Evaluation of glucose uptake by skeletal muscle tissue and subcutaneous fat in HIV-infected patients with and without lipodystrophy using FDG-PET.
Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Biological Transport; Female; Fluorodeoxyglucose F18; Glucose; HIV Infections; Humans; Insulin Resistance; Lipodystrophy; Male; Middle Aged; Muscle, Skeletal; Positron-Emission Tomography; Subcutaneous Fat; Treatment Outcome; Young Adult | 2010 |
2 other study(ies) available for fluorodeoxyglucose f18 and Lipodystrophy
| Article | Year |
|---|---|
The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Cardiomyopathy in a Diabetic Lipodystrophic Mouse Model.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; Cardiomyopathy, Hypertrophic; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Disease Models, Animal; Echocardiography; Fluorodeoxyglucose F18; Glucosides; GTP-Binding Protein gamma Subunits; Heart; Heterotrimeric GTP-Binding Proteins; Hyperglycemia; Hypoglycemic Agents; Lipodystrophy; Magnetic Resonance Imaging; Mice; Mice, Knockout; Myocardium; Pioglitazone; Positron-Emission Tomography; Radiopharmaceuticals; Sodium-Glucose Transporter 2 Inhibitors; Thiazolidinediones; Ventricular Dysfunction, Left; Ventricular Function | 2017 |
Impaired glucose phosphorylation and transport in skeletal muscle cause insulin resistance in HIV-1-infected patients with lipodystrophy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiretroviral Therapy, Highly Active; Biological Transport; Body Composition; Fatty Acids, Nonesterified; Fluorodeoxyglucose F18; Glucose; HIV-1; Humans; Insulin Resistance; Lipodystrophy; Male; Middle Aged; Muscle, Skeletal; Phosphorylation; Tomography, Emission-Computed | 2002 |